Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ: VNDA · Real-Time Price · USD

5.06

-0.03 (-0.59%)

Aug 6, 2026, 12:10 PM EDT - Market open

Vanda Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-274.85	-220.47	-18.9	2.51	6.28	33.15
Depreciation & Amortization	13.43	11.92	9.8	4.33	2.73	2.84
Stock-Based Compensation	9.07	9.47	12.43	14.04	16.28	15.37
Other Adjustments	96.11	81.33	-12.53	-7.34	0.62	10.11
Change in Receivables	-14.78	-7.46	-13.01	-0.71	-1.09	-2.47
Changes in Inventories	-1.05	-3.47	-0.03	-0.77	-4.48	-2.23
Changes in Accounts Payable	10.54	15.82	1.71	-10.98	11.79	3.04
Changes in Other Operating Activities	17.49	3.42	4.78	11.72	-0.15	4.4
Operating Cash Flow	-142.33	-109.44	-15.76	12.8	31.98	64.21
Operating Cash Flow Growth	-	-	-	-59.98%	-50.19%	24.02%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-0.67	-1	-0.49	-0.38	-0.68	-0.55
Purchases of Intangible Assets	-10	-	-4.23	-100.67	-	-
Purchases of Investments	-16.08	-112.38	-364.77	-512.61	-349.26	-420.46
Proceeds from Sale of Investments	147.03	208.24	352.06	601.6	399.86	344.32
Investing Cash Flow	120.27	94.86	-17.43	-12.06	49.93	-76.7

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Issuance of Common Stock	-	-	-	-	0.73	3.55
Repurchase of Common Stock	-	-0.92	-	-	-	-
Net Common Stock Issued (Repurchased)	-	-0.92	-	-	0.73	3.55
Other Financing Activities	-2.79	-1.99	-0.16	-	-	-
Financing Cash Flow	-2.79	-2.91	-0.16	-	0.73	3.55

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.25	0.02	-0.16	0.05	0.27	-0.09
Net Cash Flow	-25.1	-17.47	-33.51	0.79	82.91	-9.02

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-143.01	-110.44	-16.25	12.42	31.31	63.66
Free Cash Flow Growth	-	-	-	-60.33%	-50.83%	27.38%
FCF Margin	-66.29%	-51.10%	-8.17%	6.45%	12.31%	23.69%
Free Cash Flow Per Share	-2.40	-1.87	-0.28	0.22	0.55	1.12
Levered Free Cash Flow	-235.12	-193.78	-3.14	6.42	15.49	40.65
Unlevered Free Cash Flow	-248.26	-213.69	-17.76	-1.61	12.73	40.49

SEC Filings: 10-K · 10-Q